Madge K. Shafmaster - 20 Sep 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Sep 2024, 18:56:35 UTC
Prior SEC filing
07 Jul 2022
Next SEC filing
07 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Max A. Milbury, Attorney in Fact for Madge Shafmaster

Key filing fact

Madge K. Shafmaster filed Form 4 for ProMIS Neurosciences Inc. (PMN) on 24 Sep 2024.

Key facts

  • This page summarizes Madge K. Shafmaster's Form 4 filing for ProMIS Neurosciences Inc. (PMN).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Sep 2024, 18:56.

Change

  • Previous filing in this sequence was filed on 07 Jul 2022.
  • Current net transaction value: +$255,750.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMN transaction

Common Shares

Purchase

Transaction value
$75,066
Shares
+60,000
Change %
+720%
Price
$1.25
Shares after
68,333
Date
20 Sep 2024
Ownership
Direct
PMN transaction

Common Shares

Purchase

Transaction value
$89,656
Shares
+70,000
Change %
+102%
Price
$1.28
Shares after
138,333
Date
23 Sep 2024
Ownership
Direct
PMN transaction

Common Shares

Purchase

Transaction value
$91,028
Shares
+70,000
Change %
+51%
Price
$1.30
Shares after
208,333
Date
24 Sep 2024
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .